Here, we report a model for studying wound repair based on skin regenerated from human tissue culture-expanded cells. The reconstituted skin (hRSK) responds to injury similar to that of intact human skin, and its constituent cells contribute to the healing process. As we have demonstrated that hRSK composed of GFP-labelled cells also heals "normally," we believe this model will be useful in analysing the wound repair process using genetically modified human cells.
| BACKGROUND
The repair and management of full-thickness skin wounds such as deep burns or chronic ulcers remain a clinical challenge. [1, 2] No significant new therapies have been made in the last decade due in large part to the absence of a properly humanized animal model. [2] Currently, the common mouse model for studying human skin wound healing uses either human skin grafted or tissue engineering skin transplanted onto the nude mice. [3] [4] [5] [6] [7] In the human skin graft model, the skin transplant after wounding usually repairs with contraction, a high rate of shrinkage and hypertrophic scar, and does not maintain a viable normal-looking human skin for long periods. [3, 4] The current tissue engineering skin model is not morphologically normal as it consists of a simple bilayer epidermis without appendages and an undifferentiated dermis. [5] [6] [7] We recently reported a mouse model showing regeneration of full-thickness human reconstituted skin (hRSK) using culture-expanded human cells; the histological structure of hRSK is similar to that of human skin. [8] For the present study, we test whether the hRSK mouse model could be useful for assessing human wound healing.
| QUESTION ADDRESSED
Does wounded hRSK heal like normal mouse skin?
| EXPERIMENTAL DESIGN
For these studies, hRSK was generated as described previously. [8] A 2-mm-wide full-thickness wound was created at the centre of a 3-month-old hRSK ( Figure S1B) ; an identical control wound was produced on adjacent host mouse skin ( Figures 1A or S2 Figure 1A shows healing processes at different time points after injury.
| RESULTS
The hRSK wound showed histological healing changes at 4 and 8 weeks We observed that at 1 week after injury, the entire healing epidermis expressed the undifferentiation marker K5, but did not express the differentiation markers K10 and loricrin.
At 2 weeks, the K5 and K10 were normally expressed in the basal and superbasal layers, but loricrin was only weakly expressed. At 8 weeks, all tested epidermal differentiation markers were normally expressed in the neoepidermis. These data suggest that under these conditions the healing epidermis underwent a normal differentiation programme.
Next, we tested whether the reparative cells were of human origin.
Using human-specific pan-cytokeratin antibody (pan-ck), we found the neoepidermis was positive indicating that the reparative epithelial cells are human (red, Figure 2A) ; human-specific vimentin antibody was found in the neodermis, suggesting that the reparative dermis also consisted of human cells (red, Figure 2B ). This result was further confirmed by the staining of human nuclei (HuNuclei) antibody: nearly, all neoepidermal cells (around 98%) were positive for HuNu; however, the neodermis was composed of both HuNuclei + human (52% at 2 weeks, 58% at 8 weeks) and HuNuclei − mouse cells ( Figures 2B, S6 ).
And the mouse cells were mostly CD45-positive immune cells: 63%, 43%, 38% CD45+ cells at 1, 2 and 8 weeks, respectively ( Figure S7 ).
The early healing process we observed in the wounded hRSK is very similar to that of human skin graft on nude mice; [9] however, the late stage of healing such as dermal modelling, we reported here, was not studied in other models.
As the hRSK was generated from cultured cells, it should be trivial to manipulate the cells using genetic or chemical tools. Using GFP-labelled epidermal or dermal cells, we were able to generate either green epidermis ( Figure 2C Epi-GFP, Figure S8A ) or green dermis ( Figure 2C Derm-GFP, Figure S8B ), respectively. When we wounded hRSK made of GFP-labelled cells, we observed a healing process similar to that when we used unlabelled cells. We confirmed that GFP-positive cells were found by immunofluorescence analysis of GFP antibody ( Figure 2D ). It suggested this model could be used for studying wound healing of genetically modified hRSK.
| CONCLUSIONS
Here, we reported that skin derived from human cells produce fullthickness skin on a mouse model (hRSK) and that when wounded, this skin shows a healing process close to that of mature, in situ human
The hRSK is able to heal after injury. A, The representative Images of hRSK on mice at different time points as indicated after wounding. 3-mo old hRSKs were wounded using a 2 mm biopsy punch in the center; B, Histological analysis of wounds at 1, 2, and 8 wks after wounding. Arrows indicated the wound site; C, The immunofluorescence analysis of Keratin 5 (Red) at 1, 2 and 8 wks. after wounding; D, The immunofluorescence analysis of Keratin 10 (Red) at 1, 2 and 8 wks after wounding; E, The immunofluorescence analysis of Loricrin. No loricrin expression at neo-epidermis, and weak loricrin expression at 2 wks; it normally expresses at 8 wks. Nuclear staining is by DAPI (blue). All bars=200 μm F I G U R E 2 The healing tissue was formed mainly by human cells.
A,The immunofluorescence of human specific pan-ck(red) at 2 and 8 wks, DAPI for nuclear staining; B, The Immunofluorescence of human mesenchymal cell marker hVimentin at 2 and 8 wks after wounding, DAPI for nuclear staining; C, Images of GFP expression under fluorescence microscope. The left panel shows the epidermal part of hRSK, including interfollicular epidermis, hair follicles and sebaceous glands; this hRSK was generated using GFPlabeled epidermal cells (Epi-GFP). The right panel shows the dermal part of hRSK, including dermal papilla; this hRSK, was regenerated using GFP-labeled dermal cells (Der-GFP); D, DAB staining of GFPcontaining cells (brownish) in healing tissue at 2 and 8 wks after wounding. All bars=100 μm
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FIGURE S1
The regeneration of hRSK with formation of hair follicles and dermal adipose layer
FIGURE S2
The mouse skin healed faster than that of hRSK
FIGURE S3
The hRSK healed completely after wounding FIGURE S4 Basement Membrane forms at 2 weeks after wounding
FIGURE S5
The dermal remodeling of the hRSK was still ongoing at 8 weeks after wounding
FIGURE S6
The healing tissue in the hRSK consists of human cells
FIGURE S7
The healing hRSK dermis contained mouse immune cells
FIGURE S8
The reconstitution of GFP-labeled human graft
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EMILIN3, an extracellular matrix molecule with restricted distribution in skin
